Abstract
Two cases are presented in which repeated use of the TNF-alpha blocker infliximab may have led to development of pustular skin lesions. These findings might result in an improved understanding regarding the safety of infliximab with long-term usage.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have